Last data update: Apr 29, 2024. (Total: 46658 publications since 2009)
Records 1-3 (of 3 Records) |
Query Trace: Saadine J[original query] |
---|
Michigan Screening and Intervention for Glaucoma and Eye Health through Telemedicine (MI-SIGHT): Baseline methodology for implementing and assessing a community-based program
Newman-Casey PA , Musch DC , Niziol LM , Elam AR , Zhang J , Moroi SE , Johnson L , Kershaw M , Saadine J , Winter S , Woodward MA . J Glaucoma 2021 30 (5) 380-387 PRECIS: The Michigan Screening and Intervention for Glaucoma and eye Health through Telemedicine Program leverages community engaged research, telemedicine and health coaching to overcome key logistical and psychosocial barriers to improved glaucoma screening in underserved communities. PURPOSE: To describe the methodology of the implementation and evaluation of the Michigan Screening and Intervention for Glaucoma and eye Health through Telemedicine (MI-SIGHT) Program. METHODS: The MI-SIGHT Program utilizes community engagement, telemedicine and health coaching to overcome key logistical and psychosocial barriers to glaucoma identification and care among underserved populations. The MI-SIGHT Program will be evaluated in two community clinics: Hamilton Community Health Network, a federally qualified health center in Flint, MI, and the Hope Clinic, a free clinic in Ypsilanti, MI. A Community Advisory Board including the research team and health care providers, administrators and patients from both clinics will guide program implementation. An ophthalmic technician at the community clinics will conduct screening tests for glaucoma and eye disease. The data will be transmitted via electronic health record to be reviewed by an ophthalmologist who will make recommendations for follow-up care. The ophthalmic technician will conduct a return visit to fit low-or no-cost glasses, help arrange follow-up with an ophthalmologist and provide education. Those diagnosed with glaucoma or suspected glaucoma will be randomized to standard education or personalized glaucoma education and coaching. Costs will be assessed. RESULTS: We hypothesize that the MI-SIGHT program will detect a higher prevalence rate of glaucoma than that found in the general population, improve upon presenting visual acuity, enhance vision-related quality of life and demonstrate that personalized glaucoma education and coaching improve adherence to follow-up care. CONCLUSION: The MI-SIGHT Program may serve as a model for glaucoma screening and care in high-risk communities. |
Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections
Bourne RRA , Jonas JB , Bron AM , Cicinelli MV , Das A , Flaxman SR , Friedman DS , Keeffe JE , Kempen JH , Leasher J , Limburg H , Naidoo K , Pesudovs K , Peto T , Saadine J , Silvester AJ , Tahhan N , Taylor HR , Varma R , Wong TY , Resnikoff S . Br J Ophthalmol 2018 102 (5) 575-585 BACKGROUND: Within a surveillance of the prevalence and causes of vision impairment in high-income regions and Central/Eastern Europe, we update figures through 2015 and forecast expected values in 2020. METHODS: Based on a systematic review of medical literature, prevalence of blindness, moderate and severe vision impairment (MSVI), mild vision impairment and presbyopia was estimated for 1990, 2010, 2015, and 2020. RESULTS: Age-standardised prevalence of blindness and MSVI for all ages decreased from 1990 to 2015 from 0.26% (0.10-0.46) to 0.15% (0.06-0.26) and from 1.74% (0.76-2.94) to 1.27% (0.55-2.17), respectively. In 2015, the number of individuals affected by blindness, MSVI and mild vision impairment ranged from 70 000, 630 000 and 610 000, respectively, in Australasia to 980 000, 7.46 million and 7.25 million, respectively, in North America and 1.16 million, 9.61 million and 9.47 million, respectively, in Western Europe. In 2015, cataract was the most common cause for blindness, followed by age-related macular degeneration (AMD), glaucoma, uncorrected refractive error, diabetic retinopathy and cornea-related disorders, with declining burden from cataract and AMD over time. Uncorrected refractive error was the leading cause of MSVI. CONCLUSIONS: While continuing to advance control of cataract and AMD as the leading causes of blindness remains a high priority, overcoming barriers to uptake of refractive error services would address approximately half of the MSVI burden. New data on burden of presbyopia identify this entity as an important public health problem in this population. Additional research on better treatments, better implementation with existing tools and ongoing surveillance of the problem is needed. |
Diabetic retinopathy in the SEARCH for Diabetes in Youth cohort: a pilot study
Mayer-Davis EJ , Davis C , Saadine J , D'Agostino RB Jr , Dabelea D , Dolan L , Garg S , Lawrence JM , Pihoker C , Rodriguez BL , Klein BE , Klein R , Bell RA . Diabet Med 2012 29 (9) 1148-52 AIMS: The aim of this pilot study was to generate an initial estimate of the prevalence and correlates of diabetic retinopathy in a racially and ethnically diverse sample of youth with Type 1 and Type 2 diabetes mellitus. METHODS: A pilot study was conducted among 222 individuals with Type 1 diabetes (79% non-Hispanic white, 21% other) and 43 with Type 2 diabetes (28% non-Hispanic white, 72% other), all of > 5 years duration (mean duration 6.8 years) who participated in the SEARCH for Diabetes in Youth study. Diabetic retinopathy was assessed using non-mydriatic retinal photography of both eyes. RESULTS: The prevalence of diabetic retinopathy was 17% for Type 1 diabetes and 42% for Type 2 diabetes (odds ratio 1.50, 95% CI 0.58-3.88; P = 0.40 adjusted for age, duration, gender, race/ethnicity, parental education and HbA(1c) . HbA(1c) was significantly higher among those with any diabetic retinopathy (adjusted mean 79 mmol/mol, 9.4%) vs. no diabetic retinopathy (adjusted mean 70 mmol/mol, 8.6%) (P = 0.015). LDL cholesterol was also significantly higher among those with any diabetic retinopathy (adjusted mean 107.2 mg/dl) compared with those without diabetic retinopathy (adjusted mean 97.9 mg/dl) (P = 0.04). CONCLUSIONS: The prevalence of diabetic retinopathy in contemporary young individuals was substantial, particularly among minority youth and those with Type 2 diabetes. Further long-term study of diabetic retinopathy in youth is needed. |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source:
- Powered by CDC PHGKB Infrastructure